Prof. McMurray gives an update on where we are today in the prevention of HF in diabetes patients with new diabetes drugs and talks about the next steps of treating HF in patients with and without diabetes.
This lecture by prof. John McMurray was part of a CME accredited symposium "Reshaping the future of heart failure management - Translating innovations to practice in HFpEF".
John McMurray, MD, is Professor of Cardiology and Deputy Director (Clinical) of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow and Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants from Novartis, Novo Nordisk and Pfizer.The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
- Reshaping the future of heart failure management - Translating innovations to practice in HFpEFUnderstanding and managing obesity-related HFpEF
Milton Packer, MD
- Reshaping the future of heart failure management - Translating innovations to practice in HFpEFCardiac amyloidosis: an emerging target in HFpEF?
Prof. van der Meer, MD, PhD